Antares Pharma, Inc. (ATRS)

[jab91252]

Regarding TEVA / Copaxone / generic....this is why I think one of the future pipeline products in Antares arsenal will be 'copaxone', delivered through their vibex device platform. Antares, imo, gets and understands the strategy: reformulation of existing drugs coupled with an unmet need plus, the value aspect proposition not only for Antares, but insync with managed care. Playing both sides to its advantage - win win.